Contraindicated in:
Use Cautiously in:
CV: ECG changes, hypotension, tachycardia.
Derm: photosensitivity, pigment changes, rash.
EENT: blurred vision, dry eyes, lens opacities.
Endo: galactorrhea.
GI: constipation, dry mouth, anorexia, hepatitis, ileus.
GU: pink or reddish-brown discoloration of urine, urinary retention.
Hemat: AGRANULOCYTOSIS, leukopenia.
Metab: hyperthermia.
Neuro: extrapyramidal reactions, NEUROLEPTIC MALIGNANT SYNDROME, sedation, tardive dyskinesia.
Misc: allergic reactions.
Drug-Drug:
Drug-Natural Products:
(Generic available)
Compazine, Compro
Absorption: Absorption from tablet is variable; may be better with oral liquid formulations. Well absorbed after IM administration.
Distribution: Widely distributed, high concentrations in the CNS.
Protein Binding: 90%.
Metabolism/Excretion: Highly metabolized by the liver and GI mucosa.
Half-life: Unknown.
(antiemetic effect)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | 3040 min | unknown | 34 hr |
Rect | 60 min | unknown | 34 hr |
IM | 1020 min | 1030 min | 34 hr |
IV | rapid (min) | 1030 min | 34 hr |
NDC Code*